These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 8226704)

  • 1. Infection of hemophiliacs with HIV.
    Aronson DL
    J Clin Apher; 1993; 8(2):117-9. PubMed ID: 8226704
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exposure to acellular blood products and risk of HIV infection in hemophiliacs from Belo Horizonte, Brazil.
    Proietti FA; Proietti AB; Costa MF; Antunes CM; Guimarães MD; Paulino UH; Souza CJ; Melo L; Muñoz A
    Rev Inst Med Trop Sao Paulo; 1992; 34(3):227-32. PubMed ID: 1342075
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [HIV infection among type A and B hemophiliacs].
    Vicariot M; Fressinaud E; Fiks M; Fonlupt J; Berthier AM; Guerois C; Fimbel B
    Rev Fr Transfus Hemobiol; 1993 Oct; 36(5):417-26. PubMed ID: 8259952
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Foreign-protein-mediated immunodeficiency in hemophiliacs with and without HIV.
    Duesberg PH
    Genetica; 1995; 95(1-3):51-70. PubMed ID: 7744263
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hemophilia: an amazing 35-year journey from the depths of HIV to the threshold of cure.
    White GC
    Trans Am Clin Climatol Assoc; 2010; 121():61-73; discussion 74-5. PubMed ID: 20697550
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HIV and Canada's hemophiliacs: looking back at a tragedy.
    Dunn K
    CMAJ; 1993 Feb; 148(4):609-12. PubMed ID: 8431823
    [No Abstract]   [Full Text] [Related]  

  • 7. Laboratory evidence of active HIV-1 infection in Canadians with hemophilia associated with administration of heat-treated factor VIII.
    Neumann P; O'Shaughnessy M; Remis R; Tsoukas C; Lepine D; Davis M
    J Acquir Immune Defic Syndr (1988); 1990; 3(3):278-81. PubMed ID: 2106024
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Virus in hemophilia: current status and future perspectives].
    Aguilar C; Félix Lucía J
    Sangre (Barc); 1996 Apr; 41(2):141-5. PubMed ID: 9045355
    [No Abstract]   [Full Text] [Related]  

  • 9. [Antibodies against hepatitis C virus in French hemophiliacs].
    Maisonneuve P; Laurian Y; Noël L; Guérois C; Assouvie-Gomez I; Ferrer-Le Coeur F; Verroust F; Couroucé AM; Saint-Paul B
    Rev Fr Transfus Hemobiol; 1990 Oct; 33(5):375-7. PubMed ID: 2177602
    [No Abstract]   [Full Text] [Related]  

  • 10. Hemophilia treatment. Predicting the long-term risk of HIV exposure by cryoprecipitate.
    Evatt B; Austin H; Leon G; Ruiz-Sáez A; de Bosch N
    Haemophilia; 2000 Jul; 6 Suppl 1():128-32. PubMed ID: 10982279
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Hemophilia and acquired immunodeficiency].
    Allain JP
    Rev Prat; 1989 Dec; 39(30):2674-7. PubMed ID: 2515581
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Prevention of transfusion-associated virus infections in hemophilic patients needing replacement therapy].
    Meili EO
    Beitr Infusionsther; 1989; 24():46-55. PubMed ID: 2481548
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of replacement therapy on the evolution of HIV infection in hemophiliacs.
    Berntorp E
    Thromb Haemost; 1994 Jun; 71(6):678-83. PubMed ID: 7974331
    [No Abstract]   [Full Text] [Related]  

  • 14. Prevalence and transmission of human immunodeficiency virus in Japan.
    Kurimura T; Kawatani T; Hattori N; Tsuchie H
    AIDS Res; 1986 Dec; 2 Suppl 1():S163-6. PubMed ID: 3103639
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of human immunodeficiency virus (HIV) infection among hemophiliacs in Fukuoka, Japan.
    Kashiwagi S; Hayashi J; Ikematsu H; Noguchi A; Ikeda K; Kishida K; Shirakawa M; Takenaka A; Mori R
    Microbiol Immunol; 1988; 32(8):851-5. PubMed ID: 3143898
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low risk of transmission of the human immunodeficiency virus by a solvent-detergent-treated commercial factor VIII concentrate.
    Di Paolantonio T; Mariani G; Ghirardini A; Gringeri A; Mannucci PM; Mastrullo L; De Biasi R; Giustarini G; Morfini M; Schiavoni M
    J Med Virol; 1992 Feb; 36(2):71-4. PubMed ID: 1583469
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantifying the source of infection for HIV-infected hemophiliacs in the U.K. from 1979 to 1984.
    Jewell NP
    Stat Med; 2009 May; 28(10):1464-72. PubMed ID: 19235711
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HIV infection in two brothers receiving intravenous therapy for hemophilia.
    Centers for Disease Control (CDC)
    MMWR Morb Mortal Wkly Rep; 1992 Apr; 41(14):228-31. PubMed ID: 1557013
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hemophilia. Lack of direct evidence ends claim for transfusion damages.
    AIDS Policy Law; 2001 Oct; 16(20):8. PubMed ID: 11692485
    [No Abstract]   [Full Text] [Related]  

  • 20. Firm behavior in the U.S. market for factor VIII: a need for policy?
    Nauenberg E; Sullivan SD
    Soc Sci Med; 1994 Dec; 39(12):1591-603. PubMed ID: 7846556
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.